Cristina Mugheddu

InstitutionUniversity of Cagliari
AddressCagliari
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 5 Covid-19 publications, with a maximum of 3 publications in June 2020
    All Publications
    Bar chart showing 13 publications over 6 distinct years, with a maximum of 4 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Mugheddu C, Sanna S, Atzori L, Rongioletti F. Safety of secukinumab treatment in COVID-19 affected psoriatic patients. Dermatol Ther. 2021 Jan; 34(1):e14710. PMID: 33368887.
      Citations: 4     Fields:    Translation:Humans
    2. Melis D, Mugheddu C, Sanna S, Atzori L, Rongioletti F. Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID-19 pandemic. Dermatol Ther. 2020 Jul; 33(4):e13722. PMID: 32475036.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    3. Mugheddu C, Pizzatti L, Sanna S, Atzori L, Rongioletti F. COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management. J Eur Acad Dermatol Venereol. 2020 Aug; 34(8):e376-e378. PMID: 32385859.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    4. Atzori L, Mugheddu C, Addis G, Sanna S, Satta R, Ferreli C, Atzori MG, Montesu MA, Rongioletti F. Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in Sardinia (Italy). J Eur Acad Dermatol Venereol. 2020 Jun; 34(6):e247-e248. PMID: 32294265.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    5. Mugheddu C, Dell'Antonia M, Sanna S, Agosta D, Atzori L, Rongioletti F. Successful guselkumab treatment in a psoriatic patient affected with Cornelia de Lange syndrome, and prosecution during the COVID-19 pandemic. Dermatol Ther. 2020 Jul; 33(4):e13433. PMID: 32306513.
      Citations: 1     Fields:    Translation:HumansPHPublic Health